Venrock Healthcare Capital Partners III, L.P.

Holdings History for Spyre Therapeutics, Inc. - Common Stock, par value $0.0001 per share (SYRE)

Symbol
SYRE on Nasdaq
Investment type
Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
2,685,448 shares
Security Ownership %
4.6%

Venrock Healthcare Capital Partners III, L.P. ownership in Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE)

14 Feb 2025 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,685,448 shares of Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE). This represents 4.6% ownership of the company. This is the first filing by Venrock Healthcare Capital Partners III, L.P. disclosing ownership of Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share (SYRE).